Inspiring the Next Generation Almac Group Promotes STEM Careers at W5
February 18, 2019
Craigavon, N.I., 18 Feb 2019 – Following the recent launch of W5’s new interactive MED-Lab, in association with Craigavon based Almac Group, year 10 students from post primary schools across Northern Ireland were invited to attend a hands-on Science, Technology, Engineering and Maths (STEM) careers event run in partnership with Almac and the STEM Ambassadors Programme.
The event, run as part of the NI Science Festival 2019 over two days on February 15th and 28th, gives 400 young people an insight into the pharmaceutical industry and the breadth of careers it supports through presentations and speed networking opportunities with STEM Ambassadors from both Almac and QUB.
Dr Frances Weldon, STEM Outreach Manager Almac, said, “Almac is dedicated to sharing its passion about advancing knowledge and interest in STEM subjects to as wide an audience as possible. We want to show young people, in particular, not only the many pathways into a career in Health and Life sciences but also how varied and exciting that career can be. By enabling the students to meet and hear from our employees in a fun and informal way we hope to stimulate the next generation of budding scientists, engineers, mathematicians and technologists.”
MED-Lab aims to enable STEM knowledge and understanding and among W5 visitors of all ages through interactive learning. The only exhibition of its kind in Ireland MED-Lab gives visitors the ability to explore our bodies and enables them to get hands-on with some intriguing interactive exhibits, learning how scientists at Almac discover and develop medicines and diagnostic services tests for patients globally.
About Almac Group
A unique culture delivering exceptional solutions
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5600 highly skilled personnel across 18 facilities including Europe, the US and Asia.
The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.